Prescribing intelligence for ADHD therapies

Prescriptions for most CNS stimulants to treat ADHD are increasing. In England there was a 9% year on year growth in prescription items for ADHD with nearly 2 million issued in 2020-2021.  

Medications are grouped into 12 hour or 8 hour modified release methylphenidate, immediate release methylphenidate, Lisdexamfetamine, Atomoxetine and Guafacine.

The RxIndex below monitors the performance of all modified release methylphenidate brands, the most frequently prescribed drugs for ADHD.


GPrX Data Ltd

Additional resources relating to ADHD prescribing

Additional resources coming soon!

Ready to start the conversation?

Our friendly team loves talking data. Schedule a chat or an online demo now!